Teva Investigational Site 15227 — Skillman, New Jersey

Teva Investigational Site 15227 is a clinical research site located in Skillman, New Jersey, United States 08558.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 15227 has participated in 1 clinical trials.

Therapeutic areas: Asthma.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Skillman

Browse all research sites in New Jersey · View every site in Skillman

• Princeton Center for Clinical Research
• GSK Investigational Site
• Novartis Investigative Site
• Research Site
• Altana Pharma/Nycomed
• Altana/Nycomed
• Investigational Site 12
• Forest Investigative Site 1999
• Investigational Site 19
• Amphastar Site 0020
• 205.419.01067 Boehringer Ingelheim Investigational Site
• Teva Clinical Study Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 15227?

Teva Investigational Site 15227 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 15227 conducted?

Teva Investigational Site 15227 has 1 clinical trials on record. Their work covers Asthma.

Is Teva Investigational Site 15227 accredited by Crixeo Clinical Trials?

Teva Investigational Site 15227 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 15227?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.